J&J ordered to pay $572m to Oklahoma over opioid crisis
The pharmaceutical company is planning to appeal the decision to pay the state for damages relating to the US opioid crisis.
List view / Grid view
The pharmaceutical company is planning to appeal the decision to pay the state for damages relating to the US opioid crisis.
The worldwide trade of the cephalosporin class of antibiotics will increase to $14.1 billion by the end of 2025.
Teva Pharmaceuticals, Endo Pharmaceuticals and Teikoku will pay almost $70 million to the US state for delaying drugs to keep prices high.
The FDA has announced that it has granted approval to the first nine generic drug applications for Pfizer’s Lyrica treatment.